Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07322419

Hemodynamics During Cesarean Delivery Under Spinal Anesthesia With Norepinephrine Versus Ephedrine

Echocardiographic Evaluation of Cardiac Output During Cesarean Delivery Under Spinal Anesthesia Using Norepinephrine Versus Ephedrine: A Randomized Controlled Trial

Status
Recruiting
Phase
Phase 4
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Mansoura University · Academic / Other
Sex
Female
Age
19 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Echocardiography will be used to measure cardiac output and calculate other important hemodynamic variables in healthy patients with full-term singleton pregnancy during cesarean delivery under conventional spinal anesthesia using 2 different vasopressor drugs: norepinephrine in 1 group versus ephedrine in another group.

Conditions

Interventions

TypeNameDescription
PROCEDURESpinal Anesthesia with Bupivacaine and FentanylSpinal anesthesia using 2.5 mL of 0.5% hyperbaric bupivacaine (12.5 mg) and 15 mcg of fentanyl at the L4-L5 or L3-L4 interspace
DRUGCrystalloid Coload 1000 mLRinger acetate 1000 mL will be administered over 10 minutes starting immediately after intrathecal injection
PROCEDURECesarean DeliveryLower segment cesarean section using the Pfannenstiel incision and uterine exteriorization
RADIATIONTransthoracic EchocardiographyMeasurement of cardiac output in supine position with left lateral tilt at baseline, at 1 and 10 minutes after intrathecal injection, and immediately after delivery
DRUGIntravenous Norepinephrine BolusProphylactic IV norepinephrine bolus of 6 mcg will be administered immediately after intrathecal injection, followed by rescue IV norepinephrine boluses of 3, 6, and 9 mcg when systolic blood pressure decreases below 90%, 80%, and 70% of baseline value, respectively
DRUGIntravenous Ephedrine BolusProphylactic IV ephedrine bolus of 6 mg will be administered immediately after intrathecal injection, followed by rescue IV ephedrine boluses of 3, 6, and 9 mg when systolic blood pressure decreases below 90%, 80%, and 70% of baseline value, respectively

Timeline

Start date
2026-01-01
Primary completion
2026-12-31
Completion
2026-12-31
First posted
2026-01-07
Last updated
2026-01-14

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT07322419. Inclusion in this directory is not an endorsement.